Skip to main content

Advertisement

Log in

First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction

The primary objective of this study was to investigate the percentages of women choosing watchful waiting, pessary use or surgery as first-line treatment of pelvic organ prolapse (POP). Second, the rate and cause of discontinuation of pessary use were investigated.

Methods

A retrospective chart review was conducted on 794 patients referred with POP at a Danish tertiary center for urogynecology at Aalborg University Hospital between 1 January 2014 and 31 December 2015. The following data were registered: age, BMI, previous use of a pessary, total number of births, vaginal births, cesarean sections, previous hysterectomy, prolapse surgery and incontinence surgery, smoking, menopause, sexual status and POP-Q stage in the three vaginal compartments. Pessary treatments were evaluated after 3 months. Additional visits, reason for discontinuation and secondary treatment were noted.

Results

First-line treatment was surgery in 50%, watchful waiting in 33% and pessary use in 17% of patients. Characteristics associated with choosing surgery instead of a pessary were age < 65 years, previous prolapse surgery, prolapse in the anterior or posterior compartment, and POP-Q stage > 2. Characteristics associated with choosing watchful waiting instead of a pessary were age < 65 years and prolapse in the posterior compartment. A total of 33% discontinued pessary treatment within the first 3 months. Discontinuation was associated with age < 65 years, previous hysterectomy and pelvic surgery, and additional visits. Expulsion of the pessary and pain/discomfort were the main causes of discontinuation.

Conclusion

This study showed that 50% of patients referred with POP were treated with conservative treatment (watchful waiting and pessary) and thus more women could probably be treated in primary care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Samuelsson EC, Victor A, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999;180(2 Pt I):299–305.

    Article  CAS  PubMed  Google Scholar 

  2. Hendrix S, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186:1160–6.

    Article  PubMed  Google Scholar 

  3. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369(9566):1027–38.

    Article  PubMed  Google Scholar 

  4. Barber MD. Pelvic organ prolapse. BMJ. 2016;354:i3853.

    Article  PubMed  Google Scholar 

  5. Kuncharapu I, Majeroni BA, Johnson DW. Pelvic organ prolapse. Am Fam Physician. 2010;81(9):1111–7.

    PubMed  Google Scholar 

  6. Weber AM, Richter HE. Pelvic organ prolapse. Obstet Gynecol. 2005;106(3):615–34.

    Article  PubMed  Google Scholar 

  7. Hampton BS. Pelvic organ prolapse. Med Health Rhode Island. 2009;92(1):5–9.

    Google Scholar 

  8. Culligan PJ. Nonsurgical management of pelvic organ prolapse. Obstet Gynecol. 2012;119(4):852–60.

    Article  PubMed  Google Scholar 

  9. Heit M, Rosenquist C, Culligan P, Graham C, Murphy M, Shott S. Predicting treatment choice for patients with pelvic organ prolapse. Obstet Gynecol. 2003;101(6):1279–84.

    PubMed  Google Scholar 

  10. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465–93.

    Article  CAS  PubMed  Google Scholar 

  11. Coolen AWM, Troost S, Mol BWJ, Roovers JWR, Bongers MY. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery. Int Urogynecol J. 2018;29(1):99–107.

  12. Abdool Z, Swart P. Symptomatic pelvic organ prolapse: experience at a tertiary urogynaecology clinic. S Afr J Obstet Gynaecol. 2016;22(1):18–20.

    Google Scholar 

  13. Nemeth Z, Farkas N, Farkas B. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse? Int Urogynecol J. 2017;28(5):757–61.

    Article  PubMed  Google Scholar 

  14. Friedman S, Sandhu KS, Wang C, Mikhail MS, Banks E. Factors influencing long-term pessary use: reply by the authors. Int Urogynecol J. 2010;21(6):673–8.

    Article  PubMed  Google Scholar 

  15. Mutone MF, Terry C, Hale DS, Benson JT. Factors which influence the short-term success of pessary management of pelvic organ prolapse. Am J Obstet Gynecol. 2005;193(1):89–94.

    Article  PubMed  Google Scholar 

  16. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025–9.

    Article  PubMed  Google Scholar 

  17. Ding J, Chen C, Song X, Zhang L, Deng M, Zhu L. Changes in prolapse and urinary symptoms after successful fitting of a ring pessary with support in women with advanced pelvic organ prolapse: a prospective study. Urology. 2016;87:70–5.

    Article  PubMed  Google Scholar 

  18. Gilchrist AS, Campbell W, Steele H, Brazell H, Foote J, Swift S. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32(4):383–6.

    Article  PubMed  Google Scholar 

  19. Yamada T, Matsubara S. Rectocoele, but not cystocoele, may predict unsuccessful pessary fitting. J Obstet Gynaecol (Lahore). 2011;31(5):441–2.

    Article  CAS  Google Scholar 

  20. Wolff B, Williams K, Winkler A, Lind L, Shalom D. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse. Int Urogynecol J. 2017;28(7):993–7.

    Article  PubMed  Google Scholar 

  21. Geoffrion R, Zhang T, Lee T. Clinical characteristics associated with unsuccessful pessary fitting outcomes. Obstet Gynecol Surv. 2014;69(2):79–81.

    Article  Google Scholar 

  22. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(2):345–50.

    Article  PubMed  Google Scholar 

  23. Lone F, Thakar R, Sultan AH, Karamalis G. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. Int J Gynecol Obstet. 2011;114(1):56–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janani Kantharooban Umachanger.

Ethics declarations

Financial disclaimer

None.

Conflict of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Umachanger, J.K., Marcussen, M.L., Bøggild, H. et al. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment. Int Urogynecol J 31, 1813–1819 (2020). https://doi.org/10.1007/s00192-020-04338-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-020-04338-w

Keywords

Navigation